I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inno-Gene SA
Total Current Liabilities Peer Comparison

Comparables:
M
MDB
R
RVU
S
SLV

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Total Current Liabilities
zł2.5m
CAGR 3-Years
-38%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
M
Medicofarma Biotech SA
WSE:MDB
Total Current Liabilities
zł3.3m
CAGR 3-Years
74%
CAGR 5-Years
40%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Total Current Liabilities
zł89.2m
CAGR 3-Years
48%
CAGR 5-Years
47%
CAGR 10-Years
20%
S
Selvita SA
WSE:SLV
Total Current Liabilities
zł106.8m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inno-Gene SA's Total Current Liabilities?
Total Current Liabilities
2.5m PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Total Current Liabilities amounts to 2.5m PLN.

What is Inno-Gene SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-3%

Over the last year, the Total Current Liabilities growth was 49%. The average annual Total Current Liabilities growth rates for Inno-Gene SA have been -38% over the past three years , -6% over the past five years , and -3% over the past ten years .

Back to Top